-
Esculetin Blocks CKLF1-Linked Neutrophil Infiltration
2026-09-15
This study identifies CKLF1-mediated neutrophil recruitment as a mechanistic link between post-stroke inflammation and impaired recovery. In a photothrombotic mouse model, esculetin reduced infarct burden, improved neurological behavior, and enhanced motor-network activity while suppressing the CKLF1/CCR5 axis, with genetic evidence that its efficacy depends on CKLF1-related signaling.
-
Bazedoxifene: Reliable ER Assay Workflows
2026-09-15
Learn how Bazedoxifene (SKU A3232) can improve the interpretation, handling, and reproducibility of estrogen-receptor-focused viability and proliferation assays. This scenario-based guide connects receptor pharmacology with practical stock preparation, controls, readout selection, and vendor evaluation.
-
Natural Compounds Against SARS-CoV-2: Docking Evidence
2026-09-14
This 2022 Journal of Molecular Modeling study introduced a dual-target computational strategy that screened vitamin-related natural compounds against both the SARS-CoV-2 spike receptor-binding domain and 3CL protease. Its prioritized candidates provide hypotheses for blocking viral entry and polyprotein processing, but the docking and molecular dynamics results require biochemical, cellular, and pharmacological validation.
-
Etoposide (VP-16) Workflow for DNA Damage Assays
2026-09-14
Build more informative cancer biology experiments with Etoposide (VP-16), from topoisomerase II inhibition and DNA double-strand break measurement to apoptosis and viability profiling. This guide combines practical DMSO handling, dose–time design, troubleshooting, and translational context for reproducible cancer chemotherapy research.
-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-09-13
The reference review presents dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States, emphasizing its rapid, predictable anticoagulant activity and reduced dependence on routine coagulation monitoring. Its prodrug design, carboxylesterase-mediated activation, lack of cytochrome P450 involvement, renal dosing requirements, and evidence across venous thromboembolism and atrial fibrillation provide a framework for interpreting both its clinical value and its limitations.
-
Tamoxifen Workflows for CreER and Cancer Research
2026-09-12
Tamoxifen combines estrogen-receptor modulation with practical utility in inducible genetics, cancer-cell assays, and mechanism-focused screening. This workflow guide covers stock preparation, CreER-mediated gene knockout, assay controls, troubleshooting, and how a SERM repurposing study informs cross-domain experimental design.
-
1-methyl Adenosine: Assay Workflows
2026-09-11
Turn 1-methyl Adenosine from a modified nucleoside into both an experimental reagent and a measurable RNA-turnover endpoint. An isomer-resolved UHPLC–MS/MS strategy adds matrix control, sensitivity, and practical rigor for RNA modification research, cancer metabolism studies, and biomarker discovery.
-
Norepinephrine Bitartrate: From Dose to Design
2026-09-11
Norepinephrine bitartrate is more than a vasoconstrictor: it is a powerful tool for connecting receptor pharmacology with cardiovascular model design. This guide explains how salt form, exposure, assay context, and clinical conversion data should shape reproducible research workflows.
-
Human SAN-Plexus Assembloids and Pacemaker Maturation
2026-09-10
This study introduces human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac plexus, and atrial-like tissues to model neural regulation of pacemaker maturation and conduction. By integrating electrophysiology with human SAN spatial transcriptomics, the authors identify a CGPO-derived prosaposin–GPR37 signaling program that links cardiac innervation to pacemaker development.
-
PRMT5, Splicing, and Metabolism in MYCN Neuroblastoma
2026-09-10
The reference study shows that MYCN-amplified neuroblastoma is unusually dependent on PRMT5-regulated splicing, which connects spliceosomal disruption with epitranscriptomic control and glutamine metabolism. Its integrated use of transcriptomics, isotope tracing, RNA modification analysis, and mouse validation provides a mechanistic framework for studying metabolically coupled vulnerabilities in high-risk neuroblastoma.
-
Machine Learning-Designed LNPs for Microglial mRNA
2026-09-09
Rafiei and colleagues developed a machine learning-assisted workflow for selecting lipid nanoparticles that deliver mRNA to inflammatory microglia and promote an anti-inflammatory phenotype. The study combines a 216-formulation LNP library, morphometric cell analysis, supervised classifiers, and validation in murine and human iPSC-derived microglia, identifying HA-LNP2 as a promising carrier for IL10 mRNA.
-
nor-Binaltorphimine Dihydrochloride in Pain Circuits
2026-09-09
A mechanistic guide to using nor-Binaltorphimine dihydrochloride to interrogate spinal κ-opioid receptor signaling within brain-to-spinal circuits that regulate the laterality and persistence of mechanical allodynia.
-
S Tag Peptide (A6007): Practical Workflow Guide
2026-09-08
S Tag Peptide provides a compact S-peptide fusion tag for recombinant protein detection, antibody-based purification workflows, and protein solubility improvement. This guide explains construct design, aqueous or DMSO handling, QC, and limitations; it is not intended for ethanol-based workflows or independent enzymatic activity.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-09-08
The reference study identifies MDM1 as more than a response-associated biomarker: it functions through a YBX1–TP53 regulatory axis to influence apoptosis and colorectal cancer chemoradiotherapy sensitivity. Its combined cellular, transcriptomic, mechanistic, and xenograft evidence supports MDM1 as a candidate predictive marker while highlighting apoptosis modulation as a possible strategy for resistant disease.
-
Latrunculin A for Actin Dynamics Workflows
2026-09-07
Latrunculin A enables controlled, reversible actin perturbation for rapid cytoskeleton disaggregation, morphology assays, and mechanobiology experiments. This workflow connects dose-and-washout design with stiffness-dependent DRG axon regeneration research, helping investigators separate actin-driven phenotypes from upstream mechanical signaling.